The emergence and spread of antibiotic resistance is one of the biggest challenges in public
health. There is an urgent need to discover novel agents against the occurrence of multidrug …

The use of liposomes as drug carriers in treatment of various diseases has been explored
extensively for more than 20 years.'Conventional'liposomes, when administered in vivo by a …

After a short description of the results of Victor Najjar's research on tuftsin and of the
discoveries done by other authors in the early stage of tuftsin investigation, the current state …

Ever since pure molecular entities have been adapted as drug, varied manifestations other
than elimination of infections are frequently been acknowledged as side effects …

The antitubercular activity of rifampin was considerably increased when it was encapsulated
in egg phosphatidylcholine liposomes. A further increase in the activity was observed when …

Tuberculosis (TB) is among the greatest public health and safety concerns in the 21st
century Mycobacterium tuberculosis, which causes TB, infects alveolar macrophages and …

Chemotherapeutic efficacy of the amphotericin B (Amp B), which is the drug of choice for
treatment of the leishmanial infections (kala-azar) that become resistant to the conventional …

Tuftsin is a tetrapeptide (Thr-Lys-Pro-Arg) that specifically binds monocytes, macrophages,
and polymorphonuclear leukocytes and potentiates their natural killer activity against tumors …

Encapsulation of amphotericin B in tuftsin‐bearing liposomes greatly increased its efficacy in
treatment of human aspergillosis in mice. Also, the drug efficacy was significantly increased …

Liposomes are artificial vesicles composed of one or more concentric bi-layers which
enclose an aqueous space. Water-soluble drugs or biomolecules are known to be …